Detection of Bone Marrow Metastases With Magnetic Resonance Imaging
NCT03876392 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2021-08-12
Summary
The goal of this clinical trial is to study the value and feasibility of magnetic resonance imaging in detection of bone marrow metastases
Conditions
- Bone Marrow Metastases
- Magnetic Resonance Imaging
Interventions
- DIAGNOSTIC_TEST
-
magnetic resonance imaging
Compare bone marrow biopsy with magnetic resonance imaging to detect bone marrow metastases
Sponsors & Collaborators
-
Shanghai 6th People's Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-05-10
- Primary Completion
- 2022-12-01
- Completion
- 2022-12-31
Countries
- China
Study Locations
More Related Trials
-
The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss
NCT03951220 ·Status: COMPLETED
-
Brain Imaging Biomarkers in Patients With Brain Metastasis
NCT04197297 ·Status: RECRUITING ·Phase: PHASE2
-
Detection of Bone Marrow Changes: Comparison of MRI and DECT
NCT01211392 ·Status: COMPLETED
-
CD70-targeted immunoPET Imaging of Malignant Cancers
NCT06852638 ·Status: RECRUITING ·Phase: PHASE2
-
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
NCT04499365 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer
NCT05392205 ·Status: COMPLETED ·Phase: NA
-
Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of Cancer
NCT04941872 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
NCT06791226 ·Status: RECRUITING ·Phase: NA
-
MRI Optimization Study in Stage III NSCLC
NCT02076282 ·Status: UNKNOWN
-
Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases
NCT00592462 ·Status: COMPLETED
-
PET Imaging Study of 68Ga-NB381 in Multiple Myeloma
NCT06385652 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion
NCT02376127 ·Status: COMPLETED
-
Comparing 68Ga-CTR-FAPI and 18F-FDG PET/ CT in Cancer Detection
NCT06945432 ·Status: COMPLETED
-
68Ga-DOTA-hLAG-3 PET Imaging of LAG-3 Expression in Cancers
NCT05346276 ·Status: COMPLETED
-
A Prospective, Multicenter, Diagnostic Study Evaluating 68Ga-BCMA PET/CT for Targeting BCMA Expression in Multiple Myeloma.
NCT07319897 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases
NCT06690736 ·Status: RECRUITING ·Phase: NA
-
The Value of Pelvic Magnetic Resonance Imaging in Detecting Bone Marrow Infiltration of Lymphoma
NCT03973164 ·Status: COMPLETED
-
18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study
NCT02938546 ·Status: UNKNOWN ·Phase: PHASE3
-
Validation of Whole Body PET/CT Foundation Model
NCT07196995 ·Status: NOT_YET_RECRUITING
-
Comparison Study Between PET/CT and Whole-Body Diffusion Weighted MRI in the Detection of Distant Malignancies
NCT06205901 ·Status: NOT_YET_RECRUITING
-
Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer
NCT04758416 ·Status: UNKNOWN
-
18F-FAPI-RGD PET/CT in Various Tumor Types
NCT06094530 ·Status: RECRUITING
-
First Human Trial of Targeting MDM2/MDMX PET Imaging
NCT06443762 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients
NCT02327442 ·Status: UNKNOWN
-
Comparing the Diagnostic Role of PET/MRI and of PET/CT Among Patients With Gastric Cancer
NCT03015298 ·Status: UNKNOWN